vTv Therapeutics Inc (VTVT)
24.36
-0.62
(-2.46%)
USD |
NASDAQ |
Apr 24, 11:58
vTv Therapeutics Cash from Operations (TTM): -19.08M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -19.08M |
September 30, 2023 | -23.05M |
June 30, 2023 | -27.04M |
March 31, 2023 | -20.17M |
December 31, 2022 | -16.02M |
September 30, 2022 | -15.56M |
June 30, 2022 | -10.33M |
March 31, 2022 | -15.03M |
December 31, 2021 | -19.31M |
September 30, 2021 | -15.10M |
June 30, 2021 | -16.94M |
March 31, 2021 | -17.74M |
December 31, 2020 | -18.00M |
September 30, 2020 | -21.66M |
June 30, 2020 | -22.42M |
March 31, 2020 | -23.13M |
December 31, 2019 | -23.02M |
September 30, 2019 | -23.01M |
June 30, 2019 | -23.08M |
Date | Value |
---|---|
March 31, 2019 | -26.91M |
December 31, 2018 | -26.86M |
September 30, 2018 | -27.32M |
June 30, 2018 | -32.83M |
March 31, 2018 | -36.14M |
December 31, 2017 | -44.56M |
September 30, 2017 | -49.66M |
June 30, 2017 | -50.61M |
March 31, 2017 | -49.52M |
December 31, 2016 | -48.21M |
September 30, 2016 | -45.75M |
June 30, 2016 | -42.85M |
March 31, 2016 | -40.08M |
December 31, 2015 | -36.95M |
September 30, 2015 | -34.96M |
June 30, 2015 | -30.69M |
March 31, 2015 | -29.15M |
December 31, 2014 | -30.78M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-27.04M
Minimum
Jun 2023
-10.33M
Maximum
Jun 2022
-19.46M
Average
-19.31M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Altimmune Inc | -75.81M |
Palatin Technologies Inc | -26.54M |
Oragenics Inc | -7.291M |
Viking Therapeutics Inc | -73.38M |
G1 Therapeutics Inc | -38.34M |